Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|April 28, 2017
Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up dataMarc Poch Martell, Nada Hamad, Elizabeth Shin, et al.
European Journal of Haematology|October 4, 2021
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell graftsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Bone Marrow Transplantation|November 21, 2019
Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantationSamantha J Mayo, Hans A Messner, Sean B Rourke, et al.
Hematology/Oncology and Stem Cell Therapy|August 15, 2023
A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment OutcomesSwe M Linn, Igor Novitzky-Basso, Omar Abduljalil, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 19, 2020
Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unitAlexander Js Bacopoulos, Lina Ho, Anjie Yang, et al.
European Journal of Haematology|March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
European Journal of Haematology|May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD ProphylaxisAhmed Alnughmush, Ruah Alyamany, Mats Remberger, et al.
Clinical Hematology International|October 1, 2021
Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease ProphylaxisMaria Queralt Salas, Arjun Datt Law, Wilson Lam, et al.
British Journal of Haematology|September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxisRuah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
Pageof 13